FMP
Jan 21, 2026
Netflix Inc (NASDAQ:NFLX) is a leading streaming service provider, offering a wide range of TV shows, movies, and original content to its subscribers worldwide. The company has been a pioneer in the streaming industry, competing with other major players like Amazon Prime Video, Disney+, and Hulu. On January 21, 2026, UBS set a price target of $95 for Netflix, which was trading at $87.26, indicating an expected increase of 8.87%.
Despite this optimistic target, Netflix's stock recently experienced a significant decline, dropping over 5% in after-hours trading. This decrease led to a $19 billion reduction in the company's market value. The decline was primarily due to a weaker-than-expected forecast for the first quarter, suggesting potential continued losses when the New York markets open.
For the current quarter, Netflix anticipates generating $12.16 billion in revenue, a 15.3% year-on-year increase. However, this falls short of Wall Street's forecast of $12.18 billion. The company also projects an EPS of $0.76, below the anticipated $0.81. These figures have contributed to the recent negative sentiment around the stock.
Despite the disappointing outlook for the first quarter, Netflix reported strong results for the fourth quarter. The company's revenue rose by 17.6% to $12.05 billion, surpassing expectations, and its EPS of $0.56 slightly exceeded consensus estimates. Netflix also reported surpassing 325 million subscribers during the holiday period, highlighting its continued growth.
For the full year, Netflix achieved $45.2 billion in revenue, reflecting a 16% increase and slightly ahead of forecasts. The company's EPS for the year was $2.53. Currently, Netflix's stock price is $87.26, with a market capitalization of approximately $398.73 billion. The stock has fluctuated between a low of $87.02 and a high of $89.90 today, with a trading volume of 97.34 million shares.
KLA Corporation (NASDAQ:KLAC) is a key player in the semiconductor industry, specializing in process control and advance...
Globus Medical, Inc. (NYSE:GMED) is a leading medical device company that specializes in the design, development, and co...